Creative Medical Technology Holdings, Inc. (CELZ)
1.05
-0.03
(-2.78%)
USD |
NASDAQ |
Sep 09, 15:46
Creative Medical Technology Holdings Price : 1.05 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 1.10 | 1.12 | 1.07 | 1.08 | 140598.0 |
| Sep 04, 2026 | 1.06 | 1.12 | 1.06 | 1.11 | 151646.0 |
| Sep 03, 2026 | 1.14 | 1.14 | 1.04 | 1.06 | 179144.0 |
| Sep 02, 2026 | 1.10 | 1.15 | 1.10 | 1.13 | 94584.00 |
| Sep 01, 2026 | 1.11 | 1.13 | 1.09 | 1.10 | 107781.0 |
| Aug 31, 2026 | 1.14 | 1.19 | 1.09 | 1.13 | 246554.0 |
| Aug 28, 2026 | 1.17 | 1.18 | 1.115 | 1.14 | 198968.0 |
| Aug 27, 2026 | 1.20 | 1.21 | 1.120 | 1.14 | 249489.0 |
| Aug 26, 2026 | 1.22 | 1.25 | 1.19 | 1.19 | 252864.0 |
| Aug 25, 2026 | 1.19 | 1.26 | 1.19 | 1.24 | 171193.0 |
| Aug 24, 2026 | 1.29 | 1.29 | 1.190 | 1.21 | 387166.0 |
| Aug 21, 2026 | 1.27 | 1.35 | 1.22 | 1.31 | 549053.0 |
| Aug 20, 2026 | 1.28 | 1.43 | 1.08 | 1.28 | 10.26M |
| Aug 19, 2026 | 1.08 | 1.17 | 1.08 | 1.12 | 605006.0 |
| Aug 18, 2026 | 1.07 | 1.13 | 1.06 | 1.08 | 314913.0 |
| Aug 17, 2026 | 1.18 | 1.18 | 1.09 | 1.10 | 443105.0 |
| Aug 14, 2026 | 1.22 | 1.28 | 1.19 | 1.22 | 679126.0 |
| Aug 13, 2026 | 1.23 | 1.25 | 1.18 | 1.24 | 816929.0 |
| Aug 12, 2026 | 1.24 | 1.28 | 1.17 | 1.20 | 1.104M |
| Aug 11, 2026 | 1.20 | 1.46 | 1.20 | 1.24 | 3.063M |
| Aug 10, 2026 | 1.28 | 1.35 | 1.12 | 1.20 | 3.852M |
| Aug 07, 2026 | 1.47 | 1.94 | 1.28 | 1.42 | 64.22M |
| Aug 06, 2026 | 1.14 | 1.75 | 1.01 | 1.15 | 272.90M |
| Aug 05, 2026 | 0.67 | 0.7049 | 0.6327 | 0.6688 | 43.28M |
| Aug 04, 2026 | 0.66 | 0.6838 | 0.64 | 0.6564 | 129860.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.81 |
| Alnylam Pharmaceuticals, Inc. | 257.61 |
| Anika Therapeutics, Inc. | 20.93 |
| Savara, Inc. | 5.385 |
| Vericel Corp. | 38.70 |
Price Related Metrics
| PS Ratio | 1197.05 |
| Price to Book Value | 0.7876 |
| Earnings Yield | -169.3% |
| Market Cap | 6.817M |